Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer - BeOne

Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer

BeOne Study ID

BGB-A317-204

ClinicalTrials.gov ID

NCT04004221

China Drug Trials ID

CTR20170071

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan